The loxoprofen sodium capsules market is growing as arthritis, musculoskeletal disorders, postoperative pain, inflammation, and ageing populations increase demand for non-opioid pain-management options. The market was valued at USD 1.46 billion in 2024 and is projected to reach USD 2.0 billion by 2032, growing at a CAGR of 4.01%. Loxoprofen sodium is a non-steroidal anti-inflammatory drug, or...